Nolatrexed
 | |
| Names | |
|---|---|
| IUPAC name
2-Amino-6-methyl-5-(4-pyridylthio)-1H-quinazolin-4-one | |
| Identifiers | |
147149-76-6  | |
| 3D model (Jmol) | Interactive image |
| ChemSpider | 97268  |
| PubChem | 108189 |
| UNII | K75ZUN743Q |
| |
| |
| Properties | |
| C14H12N4OS | |
| Molar mass | 284.34 g/mol |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| verify (what is ?) | |
| Infobox references | |
Nolatrexed is a thymidylate synthase inhibitor.[1][2]
References
- ↑ Hughes AN, Rafi I, Griffin MJ, et al. (January 1999). "Phase I studies with the nonclassical antifolate nolatrexed dihydrochloride (AG337, THYMITAQ) administered orally for 5 days". Clin. Cancer Res. 5 (1): 111–8. PMID 9918208.
- ↑ "Nolatrexed". PubChem.gov. Pub Chem. Retrieved 12 August 2014.
This article is issued from Wikipedia - version of the 9/1/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.